gadolinium chloride has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Chen, D; Chen, X; Du, Q; Huang, D; Huang, G; Jiang, Q; Li, Q; Liu, L; Pei, R; Yang, X | 1 |
1 other study(ies) available for gadolinium chloride and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
NIR-laser-triggered gadolinium-doped carbon dots for magnetic resonance imaging, drug delivery and combined photothermal chemotherapy for triple negative breast cancer.
Topics: Animals; Carbon; Cell Line, Tumor; Combined Modality Therapy; Doxorubicin; Drug Carriers; Drug Delivery Systems; Drug Therapy; Female; Gadolinium; Humans; Infrared Rays; Lasers; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Nanostructures; Phototherapy; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2021 |